menu
    • menu

    Company profile for HiberCell

    NEW Drugs in Dev: 4
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-04-20

    Virtual Booth

    Contact Supplier

    European CDMO and Gx manufacturer with 75 years of experience in delivering premium APIs to pharmaceutical partners worldwide.

    Virtual Booth

    Contact Supplier

    Granules India Limited has high volume world-class facilities for APIs, PFIs, & FDFs, serving customers in over 80 countries.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-04-20

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Decades of therapeutic and diagnostic improvements have provided considerable benefit to cancer patients battling their primary tumors. Unfortunately, those battling relapse and metastasis have not benefited as much from these advancements and they now account for the vast majority of cancer-related deaths. To this day, there are limited treatment options in this setting. At HiberCell, we are focused on developing novel ther...
    Decades of therapeutic and diagnostic improvements have provided considerable benefit to cancer patients battling their primary tumors. Unfortunately, those battling relapse and metastasis have not benefited as much from these advancements and they now account for the vast majority of cancer-related deaths. To this day, there are limited treatment options in this setting. At HiberCell, we are focused on developing novel therapeutics to overcome foundational barriers that prevent patients from living longer, cancer-free lives.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    HiberCellUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    2825 Fairview Avenue N, Roseville, MN 55113
    Telephone
    Telephone
    651.675.0300
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://hibercell.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/hibercell/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Arvo

    Arvo

    Not Confirmed

    envelop Contact Supplier

    Arvo

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Hibercell To Show HC-7366 Synergy With VEGFR-TKIs In Carcinoma
    Hibercell To Show HC-7366 Synergy With VEGFR-TKIs In Carcinoma

    14 Apr 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/04/14/3273577/0/en/HiberCell-to-Present-Preclinical-Data-Demonstrating-the-Enhanced-Antitumor-Activity-of-HC-7366-in-Combination-with-VEGFR-TKIs-in-Clear-Cell-Renal-Cell-Carcinoma-ccRCC.html

    GLOBENEWSWIRE
    14 Apr 2026
    Share Share
    AVEO Oncology, LG Chem Partner On First-In-Human Compound Deal
    AVEO Oncology, LG Chem Partner On First-In-Human Compound Deal

    04 Nov 2025

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/aveo-oncology-an-lg-chem-company-and-hibercell-enter-into-an-exclusive-development-and-option-agreement-for-first-in-human-compound-302603732.html

    PR NEWSWIRE
    04 Nov 2025
    Share Share
    HiberCell Updates Ph1b Study in ccRCC With WELIREG
    HiberCell Updates Ph1b Study in ccRCC With WELIREG

    27 May 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/05/27/3088667/0/en/HiberCell-Announces-Successful-Completion-of-Dose-Escalation-and-Enrollment-Update-for-Ph1b-Study-Evaluating-HC-7366-in-Combination-with-WELIREG-belzutifan-in-Advanced-ccRCC.html

    GLOBENEWSWIRE
    27 May 2025
    Share Share
    HiberCell Receives FDA Fast Track for HC-7366 in AML Treatment
    HiberCell Receives FDA Fast Track for HC-7366 in AML Treatment

    23 Oct 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/10/23/2967964/0/en/HiberCell-Receives-FDA-Fast-Track-Designation-for-HC-7366-for-the-Treatment-of-Relapsed-or-Refractory-Acute-Myeloid-Leukemia-AML.html

    GLOBENEWSWIRE
    23 Oct 2024
    Share Share
    HiberCell: First Patient Dosed In AML Combination Trial Of HC-7366
    HiberCell: First Patient Dosed In AML Combination Trial Of HC-7366

    28 May 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/05/28/2888943/0/en/HiberCell-Announces-First-Patient-Dosed-in-Phase-1b-Clinical-Trial-Evaluating-HC-7366-in-Combination-with-Venetoclax-and-Azacitidine-for-the-Treatment-of-Acute-Myeloid-Leukemia-AML.html

    GLOBENEWSWIRE
    28 May 2024
    Share Share
    HiberCell: First Patient Dosed In Merck Combo Trial For ccRCC
    HiberCell: First Patient Dosed In Merck Combo Trial For ccRCC

    01 May 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/05/01/2873708/0/en/HiberCell-Announces-First-Patient-Dosed-in-Clinical-Collaboration-with-Merck-Evaluating-HC-7366-in-Combination-with-WELIREG-belzutifan-in-patients-with-advanced-ccRCC.html

    GLOBENEWSWIRE
    01 May 2024
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search